Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03815435
Other study ID # KARIM-01-ENSURGERY
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2019
Est. completion date March 31, 2020

Study information

Verified date March 2023
Source University Hospital Ostrava
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The work compares the effect of different various values of arterial blood pressure on the clarity of the surgical field in pansinusoperation in patients with chronic rhinosinusitis.


Description:

The work compares the effect of different values of arterial pressure on the clarity of the surgical field in pansinus operation in patients with chronic rhinosinusitis. A secondary goal of the study is to compare circulatory parameters, depth of anaesthesia, near-infrared spectroscopy (NIRS) and consumption of hypotensives. Null hypothesis: There is no difference in the clarity of the surgical field at various levels of the mean arterial pressure. This study is being realized in accordance with the Declaration of Helsinki and has been approved by the Ethics Committee of the University Hospital Ostrava (849/2018). According to the statement of the State Institute for Drug Control of 26th April 2019 (reference number Sukl96964/2019), the trial is not considered a clinical trial of medicinal products. Study type: Single-blind study (the surgeon does not know the value of the patient's blood pressure) prospective study.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date March 31, 2020
Est. primary completion date January 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with chronic rhinosinusitis undergoing pansinusoperation - Age over 18 years - Concrete surgeon (Petr MatouĊĦek, MD, Ph.D., MBA) - Concrete anaesthetist (Michal Parma, MD) Exclusion Criteria: - Coagulopathy - Thrombocytopathies - Vascular wall disorders - Thrombophlebitis - Anticoagulation or anti-aggregation therapy - History of malignancy - Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Controlled hypotension
Controlled hypotension will be administered according to the clarity of the surgical field.

Locations

Country Name City State
Czechia University Hospital Ostrava Ostrava Moravian-Silesian Region

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Ostrava

Country where clinical trial is conducted

Czechia, 

References & Publications (4)

Athanasiadis T, Beule A, Embate J, Steinmeier E, Field J, Wormald PJ. Standardized video-endoscopy and surgical field grading scale for endoscopic sinus surgery: a multi-centre study. Laryngoscope. 2008 Feb;118(2):314-9. doi: 10.1097/MLG.0b013e318157f764. — View Citation

Kelly EA, Gollapudy S, Riess ML, Woehlck HJ, Loehrl TA, Poetker DM. Quality of surgical field during endoscopic sinus surgery: a systematic literature review of the effect of total intravenous compared to inhalational anesthesia. Int Forum Allergy Rhinol. 2013 Jun;3(6):474-81. doi: 10.1002/alr.21125. Epub 2012 Dec 19. — View Citation

Milonski J, Zielinska-Blizniewska H, Golusinski W, Urbaniak J, Sobanski R, Olszewski J. Effects of three different types of anaesthesia on perioperative bleeding control in functional endoscopic sinus surgery. Eur Arch Otorhinolaryngol. 2013 Jul;270(7):2045-50. doi: 10.1007/s00405-012-2311-1. Epub 2012 Dec 22. — View Citation

Thongrong C, Kasemsiri P, Carrau RL, Bergese SD. Control of bleeding in endoscopic skull base surgery: current concepts to improve hemostasis. ISRN Surg. 2013 Jun 13;2013:191543. doi: 10.1155/2013/191543. Print 2013. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Surgical field clarity in relation to the value of arterial pressure Clarity of the surgical field will be assessed on a scale of 0-5, according to the Boezaart's system (1995) 13 months
Secondary Blood pressure Blood pressure will be measured in the morning before surgery, on arrival at the operating theatre and further 5 minutes after anaesthesia, and every five minutes during the surgery. 13 months
Secondary Heart rate Heart rate will be measured in the morning before surgery, on arrival at the operating theatre and further 5 minutes after anaesthesia, and every five minutes during the surgery. 13 months
Secondary Depth of anaesthesia Depth of anaesthesia will be measured using the BIS value every 5 minutes 13 months
Secondary Near infrared spectroscopy (NIRS) Cerebral perfusion will be measured using the NIRS value every 5 minutes 13 months
Secondary Consumption of hypotensives Consumption of hypotensives (Nitro Pohl) will be measured in mg/hr 13 months
Secondary Blood loss Blood loss (ml) during the surgery will be measured 13 months
Secondary Recovery from anaesthesia duration The interval from the end of surgery to eye opening in minutes will be measured. 13 months
Secondary Postoperative pain Postoperative pain will be measured using the VAS (Visual Analogue Scale) upon arrival to the recovery room and the standard ward. 13 months
Secondary Cognitive function The standardised clock-drawing test will be performed at the ward, 2 hours after surgery. 13 months
Secondary Postoperative nausea The presence of postoperative nausea (YES/NO) will be observed. 13 months
Secondary Postoperative vomiting The presence of postoperative vomiting (YES/NO) will be observed. 13 months
Secondary Complications of controlled hypotension The presence of complications of controlled hypotension (stroke, myocardial infarction, kidney injury - YES/NO) will be observed. 13 months
Secondary Use of tamponade The need to use tamponade due to bleeding (YES/NO) will be observed. 13 months
Secondary Surgical revision The need for surgical revision due to bleeding (YES/NO) will be observed. 13 months
See also
  Status Clinical Trial Phase
Recruiting NCT05895929 - The Role of IL5 in Epithelial Cell Integrity Early Phase 1
Completed NCT03673956 - Topical Antibiotics in Chronic Rhinosinusitis Phase 1/Phase 2
Recruiting NCT03970655 - Functional Endoscopic Sinus Surgery Study Phase 1/Phase 2
Not yet recruiting NCT04514120 - Alsaleh-Javer Endoscopic Sinus Score (AJESS) System N/A
Recruiting NCT03963648 - NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP N/A
Recruiting NCT05009758 - Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps N/A
Active, not recruiting NCT05553951 - Adherence in Global Airways N/A
Completed NCT03563521 - Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma
Completed NCT05035654 - LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study) Phase 2
Withdrawn NCT03369574 - Study of Chronic Rhinosinusitis Symptoms in Asthma Patients Undergoing Treatment With Reslizumab
Recruiting NCT05400616 - Nasal Microbiota Transfer Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) N/A
Recruiting NCT04628442 - Tissue Immune Interaction in Nasal Polyposis
Completed NCT04041609 - LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study) Phase 2
Completed NCT04048070 - The Effect of Enhanced Recovery After Surgery in Endoscopic Sinus Surgery N/A
Recruiting NCT03439865 - Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis Early Phase 1
Recruiting NCT05857228 - Viral and Epigenetic Influences in CRSwNP
Completed NCT03122795 - Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) N/A
Recruiting NCT05295459 - Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2) Phase 3
Completed NCT04858802 - A Clinical Evaluation of PROPEL® Contour Sinus Implant N/A
Completed NCT04572516 - Botulium Toxin Type A In Non Infectious Chronic Rhinosinusitis Phase 3